About Iffat Pharmaceuticals
Iffat Pharmaceuticals is a company. Iffat Pharmaceuticals offers products and services including Aciful-MP Oral Suspension and REBISAC-DSR.
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Iffat Pharmaceuticals Private Limited
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
-$198.82 (USD)0as on Mar 31, 2017
-
EBITDA
-$198.82 (USD)0as on Mar 31, 2017
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Iffat Pharmaceuticals
Iffat Pharmaceuticals offers a comprehensive portfolio of products and services, including Aciful-MP Oral Suspension and REBISAC-DSR.
This oral suspension is produced for pain relief and is composed of Mefenamic Acid and Paracetamol.
This tablet is formulated for gastrointestinal issues and includes Domperidone and Rabeprazole.
Funding Insights of Iffat Pharmaceuticals
Detailed funding history for Iffat Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Iffat Pharmaceuticals
Investment portfolio details for Iffat Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Iffat Pharmaceuticals
Detailed financials for Iffat Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iffat Pharmaceuticals Comparisons
Peer comparison for Iffat Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Iffat Pharmaceuticals
Detailed competitors of Iffat Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iffat Pharmaceuticals
Complete news archive for Iffat Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Iffat Pharmaceuticals
Iffat Pharmaceuticals Private Limited is identified as a privately held global pharmaceutical company that engages in the production of a diverse array of quality medicines. Its mission is noted for the provision of innovative healthcare relief while ethical standards are upheld in operations. The vision involves ensuring that affordable, high-quality medicines are made accessible worldwide, with products such as oral suspensions and tablets being manufactured for various health needs. Operations are based in Mumbai, India, facilitating global reach through stringent processes.
Iffat Pharmaceuticals offers Aciful-MP Oral Suspension and REBISAC-DSR.